precisionbiosciences.com (DTIL) - Utang marang Ekuitas

Lambang korporat lan logo Precision BioSciences Inc. (DTIL)

Precision BioSciences enjoys global recognition due to its innovative ARCUS gene editing system. A team of leading biologists is developing breakthrough treatments, supported by generous research investments and competitive compensation. This chart of the asset's market value on GURU.Markets demonstrates a debt-to-equity ratio of 0.64. Its status as a niche leader and alliances with industry behemoths guarantee the brand an impeccable reputation.

DTIL: Total Utang marang Modal Precision BioSciences, Inc. 04.07.2022 - 28.10.2026

Rincian analitis lan laporan data perusahaan precisionbiosciences.com (DTIL)

- rega lan prakiraan konsensus rega:
Rega saham Precision BioSciences|DTIL - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar Precision BioSciences|DTIL - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Precision BioSciences|DTIL - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku precisionbiosciences.com|DTIL - Nilai Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Precision BioSciences|DTIL - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Precision BioSciences, Inc.|DTIL - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Precision BioSciences
Analisis dhasar perusahaan:Precision BioSciences
Produk seri precisionbiosciences.com

The development of the ARCUS platform requires significant capital expenditures; therefore, this calculation determines the ratio of debt to equity to assess the financial autonomy of Precision BioSciences (DTIL). By analyzing the company's leverage history, an investor can understand the business's degree of dependence on creditors, which is critical for confirming the asset's stability during the scaling of genome editing technologies.

Pesaing utama

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|crisprtx.com - Total Utang marang Modal|Utang marang Ekuitas GeneDx|RARE: Utang Agregat marang Ekuitas|Utang marang Ekuitas Beam Therapeutics Corp BEAM|Sarepta Corp (SRPT) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal TWST (Twist Bioscience)|Utang marang Modal 10xgenomics.com|Total Utang marang Modal NTLA (Intellia Therapeutics, Inc.)|Rasio Total Utang marang Ekuitas Stoke Therapeutics Inc (STOK)|Total Utang marang Modal BLFS|Wave Pharma - Koefisien Total Utang marang Modal|Utang marang Ekuitas MAZE (Maze Therapeutics Inc)|SION - Koefisien Total Utang marang Modal|Prime Medicine - Total Utang marang Modal|TSHA (Taysha Gene Therapies Inc) - Koefisien Total Utang marang Modal|Utang marang Ekuitas QURE (uniQure Corp)|Utang marang Modal MGTX|Utang marang Ekuitas REGENXBIO Inc. RGNX|Rasio Utang marang Ekuitas solidbio.com SLDB|Rasio Total Utang marang Ekuitas Ocugen|Rasio Kabeh Utang marang Dana Pribadi Pacific Biosciences of California, Inc. PACB|BNTC - Total Utang marang Modal|DSGN - Utang marang Ekuitas|Rocket Pharmaceuticals - Total Utang marang Modal|FDMT (4dmoleculartherapeutics.com) - Koefisien Total Utang marang Modal|Utang marang Ekuitas LXEO (Lexeo Therapeutics Inc.)|Utang marang Modal KRRO|EDIT (Editas) - Utang marang Ekuitas|Koefisien Total Utang marang Modal Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Codexis Inc CDXS|Total Utang marang Modal SGMO (Sangamo Therapeutics, Inc.)|NAUT - Koefisien Total Utang marang Modal|Total Utang marang Modal MGX|GBIO (Generation Bio) - Utang marang Modal|Utang marang Ekuitas Boundless Bio, Inc. (BOLD)|Rasio Utang marang Ekuitas Exicure Corp|Total Utang marang Modal IMNN (Imunon, Inc.)|Rasio Total Utang marang Ekuitas phiopharma.com (PHIO)|MBIO: Total Utang marang Modal|TransCode Therapeutics Inc. - Utang marang Modal|Utang marang Ekuitas BNGO (Bionano)|APDN - Koefisien Total Utang marang Modal|Total Utang marang Modal bluebird bio|Rasio Utang marang Ekuitas ImmunoPrecise Antibodies Ltd.|Omega (OMGA) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Singular Genomics Corp|RGLS (Regulus Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal SYRS (syros.com)|Utang marang Ekuitas Telesis Bio TBIO|Utang marang Ekuitas TRACON Pharmaceuticals Inc. TCON|Unity Bio (UBX) - Total Utang marang Modal